3S)-3-methyl-2-(substituted phenyl)-2-(1H-1,2,4-triazol-1-yl)methyloxiranes (21a-f) by a ring-opening reaction with 1H-1,2,3-triazole and 1H-tetrazole and evaluated for antifungal activity against Candida albicans in vitro and in vivo. The optically active oxiranes (21a--f) which serve as the key synthetic intermediates, were synthesized from 1-[(2R)-2-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxypropanoyl]morpholin e (24)
(2R,3R)-3-偶氮基-2-(取代的苯基)-1-(
1H-1,2,4-三唑-1-基)-
2-丁醇(III)由(2R,3S)-制备。 3-甲基-2-(取代的苯基)-2-(
1H-1,2,4-三唑-1-基)甲基
环氧乙烷(21a-f)与
1H-1,2,3-三唑的开环反应和
1H-四唑,并在体外和体内评估了对白色念珠菌的抗真菌活性。由1-[(2R)-2-(3,4,5,6-四氢-
2H-吡喃-2-基)氧基丙酰基合成了关键的光学中间体
环氧乙烷(21a-f)
吗啡酮e(24)和取代的
苯基溴化镁(23)通过六个步骤以立体控制方式进行。3-(1H-1,2,3,-三唑-1-基)-(IIIa)和3-(2H-2-
四唑基)-
2-丁醇(IIId)衍
生物对小鼠念珠菌病具有很强的保护作用。